Get the Stockscreener App
22.46
1.17%
0.26
After Hours:
22.46
Innoviva Inc stock is traded at $22.46, with a volume of 1.19M.
It is up +1.17% in the last 24 hours and down -4.43% over the past month.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
See More
Previous Close:
$22.20
Open:
$22.17
24h Volume:
1.19M
Relative Volume:
1.64
Market Cap:
$1.66B
Revenue:
$425.13M
Net Income/Loss:
$271.17M
P/E Ratio:
7.3512
EPS:
3.0553
Net Cash Flow:
$195.80M
1W Performance:
+2.23%
1M Performance:
-4.43%
6M Performance:
+7.16%
1Y Performance:
+19.34%
1-Day Range:
$21.95
$22.50
1-Week Range:
$21.50
$22.52
52-Week Range:
$16.52
$25.14
Innoviva Inc Stock (INVA) Company Profile
Name
Innoviva Inc
Sector
Industry
Phone
(650) 238-9600
Address
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Compare INVA vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
22.46 | 1.64B | 425.13M | 271.17M | 195.80M | 3.0553 |
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.03B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
638.88 | 67.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
806.46 | 50.76B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
297.45 | 40.12B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
151.56 | 32.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-17-26 | Initiated | BTIG Research | Buy |
| Sep-30-25 | Initiated | Goldman | Sell |
| Aug-11-25 | Initiated | Oppenheimer | Outperform |
| Jul-14-25 | Initiated | H.C. Wainwright | Buy |
| Jul-11-25 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-07-25 | Initiated | Scotiabank | Sector Outperform |
| Jun-18-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-20-22 | Initiated | Goldman | Neutral |
| Nov-20-17 | Initiated | Deutsche Bank | Hold |
View All
Innoviva Inc Stock (INVA) Latest News
Innoviva Inc. (INVA) Gains Ground Amid Sector DynamicsThematic ETF Flow - Newser
INNOVIVA INC (NASDAQ:INVA) Scores as a Value Stock with Strong Fundamentals - ChartMill
The Technical Signals Behind (INVA) That Institutions Follow - Stock Traders Daily
INVA Q1 2026 Earnings: EPS Misses Estimates Despite Modest Stock GainOpen Signal Network - Newser
Innoviva (INVA) CFO adds ESPP shares and uses stock to pay taxes - Stock Titan
Innoviva (INVA) CEO logs ESPP share grant and tax withholding on Form 4 - Stock Titan
Innoviva (NASDAQ: INVA) CAO has shares withheld to cover tax obligations - Stock Titan
Innoviva (INVA) Q1 2026 Earnings Miss by Significant: Key TakeawaysHot Momentum Watchlist - Newser
Innoviva Appoints Josephine Linden to Strengthen Board Oversight - TipRanks
Innoviva Board Shakeup Puts Governance And Valuation In Focus - Sahm
Innoviva (INVA) director receives RSU and stock option grants as board compensation - Stock Titan
Innoviva (INVA) director Josephine Linden files Form 3 showing no share ownership - Stock Titan
Innoviva announces board changes and appoints Josephine Linden as director - Investing.com
Innoviva (INVA) refreshes board as two directors resign, adds Josephine Linden - Stock Titan
Armata Pharmaceuticals Announces First Quarter 2026 Results and Provides Corporate Update - Sahm
Armata Pharmaceuticals (ARMP) Q1 2026: EPS -3.16 Misses Est. -0. - GuruFocus
Precision Trading with Innoviva Inc. (INVA) Risk Zones - Stock Traders Daily
Armata Pharmaceuticals (ARMP) now 82.7% owned by Innoviva after new loan - Stock Titan
Armata (NYSE: ARMP) loss, debt surge and Phase 3 bacteremia trial plan - Stock Titan
Armata Pharma Entered Into Secured Credit Agreement With Innoviva for $25 M Maturing in 2029 >ARMP - Moomoo
Press Release: Armata Pharmaceuticals Announces First Quarter 2026 Results and Provides Corporate Update - Moomoo
Innoviva Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress - Quantisnow
TradingKey - TradingKey
Why are smart money investors paying attention to Innoviva (INVA)? (Mini Rally) 2026-05-11Professional Trade Ideas - newser.com
Is Innoviva (INVA) Pricing Look Compelling After Recent Share Price Softness? - Yahoo Finance
What Innoviva (INVA)'s Profit Rebound and ESOP Share Filing Means For Shareholders - simplywall.st
Innoviva Inc Emerges as Top Small Cap Value Stock with High Royalty Revenues - HarianBasis.co
Innoviva (INVA) Q1 Profit Swing Challenges Bearish Earnings Decline Narratives - Sahm
Innoviva, Inc. (INVA) Draws Bullish View from Cantor on Recurring Royalty Strength - Insider Monkey
INVA SEC FilingsInnoviva 10-K, 10-Q, 8-K Forms - Stock Titan
BTIG Maintains Innoviva(INVA.US) With Buy Rating, Raises Target Price to $42 - Moomoo
Goldman Sachs Maintains Innoviva(INVA.US) With Sell Rating, Raises Target Price to $18 - Moomoo
MSN Money - MSN
Innoviva: Q1 Earnings Snapshot - theheraldreview.com
Innoviva Reports First Quarter 2026 Financial Results; Highlights Recent Company Progress - BioSpace
Innoviva (INVA) Tops Q1 Earnings Estimates - Yahoo Finance
Innoviva Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Innoviva (INVA) grants RSUs and stock options to director Haimovitz - Stock Titan
Earnings Flash (INVA) Innoviva, Inc. Reports Q1 Revenue $98.0M, vs. FactSet Est of $101.6M - marketscreener.com
Innoviva | 10-Q: Q1 2026 Earnings Report - Moomoo
[10-Q] Innoviva, Inc. Quarterly Earnings Report - Stock Titan
Innoviva (NASDAQ: INVA) posts strong Q1 2026 profit on investment gains - Stock Titan
Innoviva (NASDAQ: INVA) director gets RSUs and 10,000 stock options at $22.99 - Stock Titan
Innoviva (INVA) awards RSUs and stock options to accounting chief - Stock Titan
Innoviva (NASDAQ: INVA) director receives RSUs and 10,000 stock options - Stock Titan
[Form 4] Innoviva, Inc. Insider Trading Activity - Stock Titan
Innoviva (NASDAQ: INVA) director granted RSUs and 10,000 stock options - Stock Titan
Tranche Update on Innoviva, Inc.'s Equity Buyback Plan announced on November 5, 2025. - marketscreener.com
What Innoviva (INVA) does that builds long term value | Q4 2025: Better Than ExpectedBrand Strength - newser.com
Innoviva Inc (INVA) - MSN
Innoviva, Inc. 8-K SEC Filing – Company Information, Address, and Stock Details for May 2026 - Minichart
Innoviva Inc Stock (INVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.98%
1.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):